The Blog

Tracking developments across news, scientific publications, patents, FDA events, earnings, and financial documents can be overwhelming. Mindgram automates this process, providing a comprehensive view of relevant data. Its Watchl List and AI-powered Summary Digest feature summarizes information around drugs, companies, and/or indications into professional-grade reports, easily shared with internal teams, and can be filtered to certain time periods.

We are at a unique moment in history where the speed of new innovation and breakthrough discoveries in biotech is accelerating in a non-linear fashion. In 2021, biotech companies raised north of $60 billion from investors and equity markets, marking the year as the biggest of all time. 

Wall Street has traditionally relied on human analysts and reporters to map political and regulatory risks emanating from Washington. From my own experience as an analyst, it is clear to me that traditional models of Washington-driven investment research are outdated, constrained in their scope, and only solve a fraction of the overall research problem.